Anaplastic Thyroid Carcinoma

[1]  B. Guo,et al.  A Novel Multimodal Therapy for Anaplastic Thyroid Carcinoma: 125I Seed Implantation Plus Apatinib After Surgery , 2020, Frontiers in Endocrinology.

[2]  K. Segers,et al.  Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma , 2019, Case reports in endocrinology.

[3]  Minetta C. Liu,et al.  A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. , 2019, Thyroid : official journal of the American Thyroid Association.

[4]  K. Nakano,et al.  A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer. , 2019, Future oncology.

[5]  M. Javid,et al.  Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer , 2017, Molecular and Cellular Endocrinology.

[6]  Michelle D. Williams,et al.  Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer , 2017, Head & neck.

[7]  A. Miyauchi,et al.  The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study. , 2016, Thyroid : official journal of the American Thyroid Association.

[8]  N. Besic,et al.  The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis. , 2016, European journal of cancer.

[9]  S. Beriwal,et al.  Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival , 2016, Head & neck.

[10]  Kristen A Marten,et al.  Use of vemurafenib in anaplastic thyroid carcinoma: a case report , 2015, Cancer biology & therapy.

[11]  B. Jarzab,et al.  Sorafenib for the treatment of thyroid cancer: an updated review , 2015, Expert opinion on pharmacotherapy.

[12]  S. Piana,et al.  Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer , 2014, International journal of endocrinology.

[13]  J. Shah,et al.  Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience , 2014, Annals of Surgical Oncology.

[14]  A. Garden,et al.  Chemoradiation in anaplastic thyroid carcinomas. , 2013, Critical reviews in oncology/hematology.

[15]  Y. Nikiforov,et al.  American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[16]  Andrea K. Kukla,et al.  A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  A. Miyauchi,et al.  Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients , 2012, World Journal of Surgery.

[18]  B. Niederle,et al.  High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel. , 2010, The Journal of clinical endocrinology and metabolism.

[19]  G. Pentheroudakis,et al.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  H. Risch,et al.  Changing incidence of thyroid cancer. , 2006, JAMA.

[21]  M. Schlumberger,et al.  Anaplastic Thyroid Carcinoma , 2003 .

[22]  E. Baudin,et al.  Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. , 2004, International Journal of Radiation Oncology, Biology, Physics.